Woolsey Pharmaceuticals, Inc. — Form D/A
Woolsey Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2020-04-08. $8.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-08
- Form: D/A
- Accession: 0001804846-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $8.6M
- Investors: 54
- Date of first sale: 2020-02-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361938
Issuer
- Name: Woolsey Pharmaceuticals, Inc.
- CIK: 0001804846
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 233 BROADWAY, SUITE 1750, NEW YORK, NY, 10279
- Phone: 212-586-2226
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| SVEN M JACOBSON | Director | NEW YORK, NY |
| SVEN M JACOBSON | Executive Officer | NEW YORK, NY |
| DAVID M GELIEBTER | Director | NEW YORK, NY |
| DAVID M GELIEBTER | Executive Officer | NEW YORK, NY |
Other filings by this issuer (2)
More